Immunologic mechanisms of extracorporeal photochemotherapy in chronic graft-versus-host disease
G Gorgun, KB Miller, FM Foss - Blood, The Journal of the …, 2002 - ashpublications.org
Extracorporeal photochemotherapy (ECP) has been shown to be an effective therapy for
patients with acute and chronic graft-versus-host disease (GVHD) following allogeneic bone …
patients with acute and chronic graft-versus-host disease (GVHD) following allogeneic bone …
Immunologic mechanisms of extracorporeal photochemotherapy in chronic graft-versus-host disease.
G Gorgun, KB Miller, FM Foss - Blood, 2002 - europepmc.org
Extracorporeal photochemotherapy (ECP) has been shown to be an effective therapy for
patients with acute and chronic graft-versus-host disease (GVHD) following allogeneic bone …
patients with acute and chronic graft-versus-host disease (GVHD) following allogeneic bone …
Immunologic mechanisms of extracorporeal photochemotherapy in chronic graft-versus-host disease
G Gorgun, KB Miller, FM Foss - Blood, 2002 - ohsu.elsevierpure.com
Extracorporeal photochemotherapy (ECP) has been shown to be an effective therapy for
patients with acute and chronic graft-versus-host disease (GVHD) following allogeneic bone …
patients with acute and chronic graft-versus-host disease (GVHD) following allogeneic bone …
[PDF][PDF] Immunologic Mechanisms of Extracorporeal Photochemotherapy (ECP) in Chronic Graft-Versus Host Disease
G Gorgun, KB Miller, FM Foss - academia.edu
Extracorporeal photochemotherapy (ECP) has been shown to be an effective therapy for
patients with acute and chronic graft-vs-host disease (GVHD) following allogeneic bone …
patients with acute and chronic graft-vs-host disease (GVHD) following allogeneic bone …
[HTML][HTML] Immunologic mechanisms of extracorporeal photochemotherapy in chronic graft-versus-host disease
G Gorgun, KB Miller, FM Foss - Blood, 2002 - Elsevier
Extracorporeal photochemotherapy (ECP) has been shown to be an effective therapy for
patients with acute and chronic graft-versus-host disease (GVHD) following allogeneic bone …
patients with acute and chronic graft-versus-host disease (GVHD) following allogeneic bone …
Immunologic mechanisms of extracorporeal photochemotherapy in chronic graft-versus-host disease
G Gorgun, KB Miller, FM Foss - Blood, 2002 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Extracorporeal photochemotherapy (ECP) has
been shown to be an effective therapy for patients with acute and chronic graft-versus-host …
been shown to be an effective therapy for patients with acute and chronic graft-versus-host …
[引用][C] Immunologic mechanisms of extracorporeal photochemotherapy in chronic graft-versus-host disease
G GORGUN, KB MILLER, FM FOSS - Blood, 2002 - pascal-francis.inist.fr
Immunologic mechanisms of extracorporeal photochemotherapy in chronic graft-versus-host
disease CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …
disease CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …
[PDF][PDF] Immunologic Mechanisms of Extracorporeal Photochemotherapy (ECP) in Chronic Graft-Versus Host Disease
G Gorgun, KB Miller, FM Foss - Citeseer
Extracorporeal photochemotherapy (ECP) has been shown to be an effective therapy for
patients with acute and chronic graft-vs-host disease (GVHD) following allogeneic bone …
patients with acute and chronic graft-vs-host disease (GVHD) following allogeneic bone …
[PDF][PDF] Immunologic Mechanisms of Extracorporeal Photochemotherapy (ECP) in Chronic Graft-Versus Host Disease
G Gorgun, KB Miller, FM Foss - researchgate.net
Extracorporeal photochemotherapy (ECP) has been shown to be an effective therapy for
patients with acute and chronic graft-vs-host disease (GVHD) following allogeneic bone …
patients with acute and chronic graft-vs-host disease (GVHD) following allogeneic bone …
Immunologic mechanisms of extracorporeal photochemotherapy in chronic graft-versus-host disease
G Gorgun, KB Miller, FM Foss - Blood, 2002 - pubmed.ncbi.nlm.nih.gov
Extracorporeal photochemotherapy (ECP) has been shown to be an effective therapy for
patients with acute and chronic graft-versus-host disease (GVHD) following allogeneic bone …
patients with acute and chronic graft-versus-host disease (GVHD) following allogeneic bone …